Home · Science · Oct 5 archive

Space Radiation Linked to Cancer Risk in Astronauts

Confirmed

Science Desk

In Short: According to Oren Milstein, CEO of StemRad, a single major solar particle event can deliver more than one-third of NASA’s 600 millisievert career effective-dose limit, which corresponds to a 3% mortality risk from radiation-induced cancer.

Leading risk factors at the most detailed level for risk-attributable cancer age-standardised DALY rates globally, both sexes combined, 2010–19
Photo: Authors of the study: GBD 2019 Cancer Risk Factors Collaborators (see source) / Wikimedia Commons (CC BY 4.0)

The complexity of the radiation environment in deep space poses a significant challenge for human space exploration, according to a recently published Radiation White Paper by the European Space Agency (ESA).

One of the major hurdles is the exposure to space radiation, which can lead to detrimental health risks and electronics damage.

To address this, StemRad Radiation Protection developed the AstroRad vest, which was tested during the uncrewed Artemis I flight in 2022.

The vest, designed to shield astronauts from harmful radiation, was shown to reduce the effective dose by around 60% in an August 1972-type scenario and by almost 40% for a 1989-type solar particle event.

The AstroRad vest uses varying thicknesses of shielding throughout the garment to protect organs that are more sensitive to radiation, such as breasts, colon, lungs, ovaries, stomach, and red bone marrow.

The vest allows astronauts to move around the cabin and continue mission-critical tasks, providing a similar level of protection to the most robust shelter configuration.

The findings suggest that the AstroRad vest could significantly reduce the radiation dose astronauts might receive during deep space travel.

In addition to physical protection, a study presented at the American Society for Radiation Oncology (ASTRO) 2026 Annual Meeting found that psychotherapy for major depressive disorder (MDD) within a month of cancer diagnosis was associated with a 21% reduced risk of cancer-specific mortality.

Fumiko Chino, MD, a radiation oncologist at The University of Texas MD Anderson Cancer Center, emphasized the importance of individualizing depression management in cancer care.

These advancements in radiation protection and mental health care aim to ensure the safety and well-being of astronauts during long-duration space missions.

What this adds

The AstroRad vest was tested using numerous radiation dosimeters placed in and on phantoms to compare the received radiation dose.

The vest was tested alongside a companion phantom that did not wear the vest, allowing for direct comparison of radiation exposure.

Background

The study also found that depression was least common among patients with prostate cancer, but these patients showed the highest risk for cancer-specific mortality.

What's confirmed

What's still developing

Sources